Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF NOVEMBER 03, 2021 SAM #7277
SOLICITATION NOTICE

44 -- Uranyl Nitrate Natural Convention Medical Isotope Reactor

Notice Date

11/1/2021 12:03:24 PM
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

221113 — Nuclear Electric Power Generation
 

Contracting Office

BATTELLE ENERGY ALLIANCE�DOE CNTR Idaho Falls ID 83415 USA
 

ZIP Code

83415
 

Solicitation Number

BA-1213
 

Response Due

11/16/2021 12:10:00 PM
 

Archive Date

11/16/2021
 

Point of Contact

Andrew Rankin
 

E-Mail Address

andrew.rankin@inl.gov
(andrew.rankin@inl.gov)
 

Description

TECHNOLOGY LICENSING OPPORTUNITY Uranyl Nitrate Natural Convection Medical Isotope Reactor This reactor concept is a uranyl nitrate nuclear reactor that will generate medical isotopes as a product of the fission reaction. Opportunity:�� Idaho National Laboratory (INL), managed and operated by Battelle Energy Alliance, LLC (BEA), is offering the opportunity to enter into a license and/or collaborative research agreement to commercialize this uranyl nitrate nuclear reactor concept. This technology transfer opportunity is part of a dedicated effort to convert government-funded research into job opportunities, businesses and ultimately an improved way of life for the American people. Description:�� �This invention is a uranyl nitrate nuclear reactor that will generate medical isotopes as a product of the fission reaction. The fuel and subsequently the medical isotopes will be in the uranyl nitrate solution and will thus be readily available for extraction on-line, while the reactor continues to operate. A byproduct of the reactor will be the thermal energy produced, which can either generate electricity or thermal energy for district heating. The reactor is extremely safe as it relies on natural convection to circulate the fuel and thus has no pumps or valves. There is a dominant negative temperature coefficient of reactivity, which allows the reactor to shut down automatically during a postulated temperature excursion. Benefits:��� ������ Significantly improved efficiency. No other reactors operating right now can produce medical isotopes. Applications:�� Medical Isotopes Development Status:� TRL 3. This technology is undergoing proof-of-concept. IP Status: ������� Provisional Patent Application No. 63/203,423, �Isotope Production Devices, Associated Components, and Systems,� BEA Docket No. BA-1213. INL is seeking to license the above intellectual property to a company with a demonstrated ability to bring such inventions to the market. Exclusive rights in defined fields of use may be available. Added value is placed on relationships with small businesses, start-up companies, and general entrepreneurship opportunities. Please visit Technology Deployment�s website at https://inl.gov/inl-initiatives/technology-deployment for more information on working with INL and the industrial partnering and technology transfer process. Companies interested in learning more about this licensing opportunity should contact Andrew Rankin at td@inl.gov.
 

Web Link

SAM.gov Permalink
(https://beta.sam.gov/opp/7013c2416f8841f089837b986072c8b9/view)
 

Place of Performance

Address: Idaho Falls, ID 83415, USA

Zip Code: 83415

Country: USA
 

Record

SN06168303-F 20211103/211101230116 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |